Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edina Poletto

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Progress in Molecular Biology and Translational Science|June 27, 2021
Genome editing in lysosomal disordersLuisa Natalia Pimentel-Vera, Edina Poletto, Esteban Alberto Gonzalez, et al.
Expert Opinion on Biological Therapy|March 15, 2023
<i>Ex vivo</i> gene therapy for lysosomal storage disorders: future perspectivesEdina Poletto, Andrew Oliveira Silva, Ricardo Weinlich, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 21, 2017
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activityGuilherme Baldo, Angela Maria Vicente Tavares, Esteban Gonzalez, et al.
Life Sciences|January 26, 2018
Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I miceEsteban Alberto Gonzalez, Giselle Renata Martins, Angela Maria Vicente Tavares, et al.
Nature Communications|July 5, 2020
Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editingSamantha G Scharenberg, Edina Poletto, Katherine L Lucot, et al.
Nature Communications|August 22, 2020
Author Correction: Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editingSamantha G Scharenberg, Edina Poletto, Katherine L Lucot, et al.
Human Gene Therapy|February 26, 2021
Biodistribution of Transplanted Hematopoietic Precursor Cells Injected Through Different Administration Routes in Newborn MiceEdina Poletto, Camila Vieira Pinheiro, Roselena Silvestri Schuh, et al.
Metabolic Brain Disease|August 27, 2022
Evaluation of oxidative stress and mitochondrial function in a type II mucopolysaccharidosis cellular model: in vitro effects of genistein and coenzyme Q10Carlos Eduardo Diaz Jacques, Franciele Fátima Lopes, Edina Poletto, et al.
Cell Biochemistry and Function|February 9, 2024
Effect of genistein and coenzyme Q10 in oxidative damage and mitochondrial membrane potential in an attenuated type II mucopolysaccharidosis cellular modelCamila Aguilar Delgado, Edina Poletto, Luisa Natalia Pimentel Vera, et al.
Current Gene Therapy|May 5, 2021
In Situ Gene TherapyHallana Souza Santos, Luiza Rodrigues, Luisa Natalia Pimentel Vera, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Progress in Molecular Biology and Translational Science|June 27, 2021
Genome editing in lysosomal disordersLuisa Natalia Pimentel-Vera, Edina Poletto, Esteban Alberto Gonzalez, et al.
Expert Opinion on Biological Therapy|March 15, 2023
<i>Ex vivo</i> gene therapy for lysosomal storage disorders: future perspectivesEdina Poletto, Andrew Oliveira Silva, Ricardo Weinlich, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 21, 2017
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activityGuilherme Baldo, Angela Maria Vicente Tavares, Esteban Gonzalez, et al.
Life Sciences|January 26, 2018
Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I miceEsteban Alberto Gonzalez, Giselle Renata Martins, Angela Maria Vicente Tavares, et al.
Nature Communications|July 5, 2020
Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editingSamantha G Scharenberg, Edina Poletto, Katherine L Lucot, et al.
Nature Communications|August 22, 2020
Author Correction: Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editingSamantha G Scharenberg, Edina Poletto, Katherine L Lucot, et al.
Human Gene Therapy|February 26, 2021
Biodistribution of Transplanted Hematopoietic Precursor Cells Injected Through Different Administration Routes in Newborn MiceEdina Poletto, Camila Vieira Pinheiro, Roselena Silvestri Schuh, et al.
Metabolic Brain Disease|August 27, 2022
Evaluation of oxidative stress and mitochondrial function in a type II mucopolysaccharidosis cellular model: in vitro effects of genistein and coenzyme Q10Carlos Eduardo Diaz Jacques, Franciele Fátima Lopes, Edina Poletto, et al.
Cell Biochemistry and Function|February 9, 2024
Effect of genistein and coenzyme Q10 in oxidative damage and mitochondrial membrane potential in an attenuated type II mucopolysaccharidosis cellular modelCamila Aguilar Delgado, Edina Poletto, Luisa Natalia Pimentel Vera, et al.
Current Gene Therapy|May 5, 2021
In Situ Gene TherapyHallana Souza Santos, Luiza Rodrigues, Luisa Natalia Pimentel Vera, et al.
Pageof 3